Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
出版年份 2023 全文链接
标题
Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
作者
关键词
-
出版物
Molecular Cancer
Volume 22, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-03-18
DOI
10.1186/s12943-023-01759-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3
- (2022) Ziwen Pan et al. Molecular Cancer
- Exosome-derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironments
- (2022) Chen Yang et al. MOLECULAR THERAPY
- The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment
- (2022) Chen Xue et al. Frontiers in Immunology
- Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
- (2022) Mingyao Huang et al. CANCER SCIENCE
- T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma
- (2022) Maryam Barsch et al. JOURNAL OF HEPATOLOGY
- Revealing anti-PD-1 resistance mechanisms in HCC: A path towards novel combination immunotherapies
- (2022) Marina Bárcena-Varela JOURNAL OF HEPATOLOGY
- Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma
- (2022) Samuel Chuah et al. JOURNAL OF HEPATOLOGY
- M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
- (2022) Ashuai Du et al. Molecular Cancer
- CircGPR137B/miR-4739/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma
- (2022) Lianyong Liu et al. Molecular Cancer
- MYB orchestrates T cell exhaustion and response to checkpoint inhibition
- (2022) Carlson Tsui et al. NATURE
- Circular RNA as a Novel Biomarker and Therapeutic Target for HCC
- (2022) Hongwu Meng et al. Cells
- Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1
- (2022) Jian Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PDL1‐positive exosomes suppress antitumor immunity by inducing tumor‐specific CD8 + T cell exhaustion during metastasis
- (2021) Ji Chen et al. CANCER SCIENCE
- Circular RNAs: characteristics, biogenesis, mechanisms and functions in liver cancer
- (2021) Hao Shen et al. Journal of Hematology & Oncology
- circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma
- (2021) Peng Li et al. MOLECULAR THERAPY
- Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
- (2021) Jia-Cheng Lu et al. Journal of Hematology & Oncology
- Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC
- (2021) Shi-Wei Chen et al. Molecular Cancer
- The emerging roles of circRNAs in cancer and oncology
- (2021) Lasse S. Kristensen et al. Nature Reviews Clinical Oncology
- Epidemiology and surveillance for hepatocellular carcinoma: New trends
- (2020) Amit G. Singal et al. JOURNAL OF HEPATOLOGY
- Translation and functional roles of circular RNAs in human cancer
- (2020) Ming Lei et al. Molecular Cancer
- Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis
- (2020) Xiao-Yong Huang et al. Molecular Cancer
- The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs
- (2020) Lele Zhang et al. Molecular Cancer
- Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
- (2020) Peng-Fei Zhang et al. Molecular Cancer
- ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1
- (2020) Yunhao Chen et al. Molecular Cancer
- β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion
- (2020) Linyong Du et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Circular RNA: metabolism, functions and interactions with proteins
- (2020) Wei-Yi Zhou et al. Molecular Cancer
- N6-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling
- (2020) Junjie Xu et al. Molecular Cancer
- TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma
- (2019) Xiaochen Wang et al. JOURNAL OF HEPATOLOGY
- Exosomal circRNAs: biogenesis, effect and application in human diseases
- (2019) Yangxia Wang et al. Molecular Cancer
- TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
- (2019) Omar Khan et al. NATURE
- WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
- (2019) Yunhao Chen et al. Molecular Cancer
- The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
- (2019) Ling Wei et al. Molecular Cancer
- PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
- (2019) Jiaqiang Ma et al. Journal for ImmunoTherapy of Cancer
- An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
- (2019) Caroline S. Jansen et al. NATURE
- CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
- (2018) Masao Hashimoto et al. Annual Review of Medicine
- T Cell Dysfunction in Cancer
- (2018) Daniela S. Thommen et al. CANCER CELL
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes
- (2017) Shengli Li et al. NUCLEIC ACIDS RESEARCH
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion
- (2016) Roberto Tinoco et al. IMMUNITY
- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Requirement of Cell Cycle and Apoptosis Regulator 1 for Target Gene Activation by Wnt and β-Catenin and for Anchorage-independent Growth of Human Colon Carcinoma Cells
- (2009) Chen-Yin Ou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now